Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 17, 3 Issues, 2022
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Most Accessed Articles







Therapeutic Approaches for COVID-19 Based on the Interferon-Mediated Immune Responses

, 2021; 16(3): 269-280.

Pouria Mosaddeghi, Farbod Shahabinezhad, Zahra Dehghani, Mitra Farahmandnejad, Mohammad Javad Taghipour, Mohsen Moghadami, Navid Nezafat, Seyed Masoom Masoompour and Manica Negahdaripour*


DOI: 10.2174/1574362416666210120104636




Development of ATP13A2-deficient In vitro Model for PARK9 Parkinson’s Disease

, 2021; 16(3): 281-292.

Yiing Jye Yap, Md Ezharul Hoque Chowdhury, Rhun Yian Koh, Soi Moi Chye, Kenny Gah Leong Voon, Iekhsan Othman and Khuen Yen Ng*


DOI: 10.2174/1574362416666210325112850











Editor-in-Chief

Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog